April 8, 2008 - Battelle, a non-profit independent research and development organization, and MEDRAD Inc. today said they won a Medical Design Excellence Award (MDEA) for the MEDRAD XDS Extravasation Detector, a technology that reportedly enhances the safety of contrast media injection through early detection of extravasations.
The MDEA competition recognizes medical product excellence and the achievements of medical product manufacturers (and the people who are responsible for groundbreaking innovations that are changing the face of healthcare). An impartial, multi-disciplinary panel of jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics reviewed the entries and selected the winners.
Battelle worked closely with MEDRAD to develop the technology from exploration through product development. MEDRAD and Battelle jointly invented the electrical permittivity technology that enables XDS and developed the commercial product.
XDS continuously monitors the tissue immediately surrounding and directly beneath the injection site for changes in relative permittivity signaling fluid accumulation.
MEDRAD and Battelle will accept the award at a ceremony on June 4, 2008 at the Medical Design and Manufacturing East 2008 Conference and Exposition in New York City.
For more information: www.medrad.com
April 12, 2024 
